Lupin and Zentiva partner to commercialize Certolizumab Pegol biosimilar globally, sharing profits and investing in ...

Global Pharma major Lupin Limited and Zentiva Group, a pan-European pharmaceutical company, have entered into a license and ...

PRAGUE, Czech Republic I July 9, 2025 I Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

Some medicines used for heart problems, like beta-blockers, ACE inhibitors, and calcium channel blockers, have been known to ...

There are different types, with plaque psoriasis being the most common kind, according to the US National Institute Of ...

The US biosimilar market expands with new denosumab options, enhancing treatment for patients with osteoporosis and ...